Abstract
An amendment to this paper has been published and can be accessed via the original article.
Highlights
In the last paragraph of the article it states that we have shown that “... higher MBDA scores at diagnosis associated with a lower risk to achieve DMARD-free remission over time...”, it should be “... higher MBDA scores at diagnosis associated with a higher risk to achieve DMARD-free remission over time...”
* Correspondence: D.M.Boeters@lumc.nl 1Department of Rheumatology C1-R, Leiden University Medical Center, PO Box 9600, Leiden 2300, RC, the Netherlands Full list of author information is available at the end of the article
Summary
In the last paragraph (first sentence) of the article it states that we have shown that “... higher MBDA scores at diagnosis associated with a lower risk to achieve DMARD-free remission over time...”, it should be “... higher MBDA scores at diagnosis associated with a higher risk to achieve DMARD-free remission over time...”. Correction to: Response to: “Does ACPAnegative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have